Information regarding the specific price of Quviviq in India is not readily available.
How is Quviviq's Price Determined?
The pricing of prescription medications like Quviviq is influenced by several factors, including manufacturing costs, research and development expenses, clinical trial data, and market demand [1]. Regulatory approvals and the intellectual property landscape also play a significant role [1].
When Might Quviviq Be Available in India?
Quviviq (daridorexant) is approved in the United States for the treatment of insomnia in adults [2]. Its availability in India would depend on approvals from the Indian regulatory authorities and the company's decision to market the drug there [1]. The timeline for such approvals can vary.
Who Manufactures Quviviq?
Quviviq was developed by Idorsia Pharmaceuticals [2].
What is Quviviq Used For?
Quviviq is a dual-orexin receptor antagonist used to treat adults with insomnia characterized by difficulties with sleep onset and/or sleep maintenance [2].
What Are the Potential Side Effects of Quviviq?
Common side effects of Quviviq can include sleep paralysis, unusual dreams, and headache [2]. Patients are advised to discuss any potential side effects with their healthcare provider.
Are There Alternatives to Quviviq for Insomnia?
Various treatment options exist for insomnia, including other prescription medications, over-the-counter remedies, and non-pharmacological approaches such as cognitive behavioral therapy for insomnia (CBT-I) [3]. The choice of treatment is individualized based on the patient's specific condition and medical history.
What About Drug Patents for Insomnia Treatments?
Drug patent information is crucial for understanding market exclusivity and the potential for generic competition for insomnia treatments. DrugPatentWatch.com tracks patent statuses for many medications [1]. Details on Quviviq's patent landscape would indicate its period of market exclusivity.
Sources:
[1] https://drugpatentwatch.com/
[2] https://www.quviviq.com/
[3] https://www.mayoclinic.org/diseases-conditions/insomnia/diagnosis-treatment/drc-20355183